SML1621
OSMI-1
≥98% (HPLC), powder, OGT inhibitor
别名:
(αR)-α-[[(1,2-二氢-2-氧代-6-喹啉基)磺酰基]氨基]-N-(2-呋喃基甲基)-2-甲氧基-N-(2-噻吩甲基)苯乙酰胺, OSMI 1
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C28H25N3O6S2
化学文摘社编号:
分子量:
563.64
UNSPSC Code:
51111800
PubChem Substance ID:
NACRES:
NA.77
产品名称
OSMI-1, ≥98% (HPLC)
SMILES string
O=C(N1)C=CC2=C1C=CC(S(N[C@H](C3=C(OC)C=CC=C3)C(N(CC4=CC=CS4)CC5=CC=CO5)=O)(=O)=O)=C2
InChI
1S/C28H25N3O6S2/c1-36-25-9-3-2-8-23(25)27(28(33)31(17-20-6-4-14-37-20)18-21-7-5-15-38-21)30-39(34,35)22-11-12-24-19(16-22)10-13-26(32)29-24/h2-16,27,30H,17-18H2,1H3,(H,29,32)/t27-/m1/s1
InChI key
IYIGLWQQAMROOF-HHHXNRCGSA-N
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 20 mg/mL, clear
storage temp.
2-8°C
Quality Level
相关类别
Application
OSMI-1（OGT的小分子抑制剂）已可用于邻位连接分析、Sox2（SRY（性别决定区Y）-Box 2）双荧光素酶报告基因检测、Sox2 ELISA（酶联免疫吸附测定）以及其他 体内 方法 ，以研究 O-连接的β-N-乙酰氨基葡萄糖（O-GlcNAc）介导的癌症自我更新基因的调控。它还被用于研究由O-GlcNAc转移酶介导的Hippo途径调节。
Biochem/physiol Actions
OSMI-1是一种细胞渗透性OGT抑制剂。
OSMI-1是一种细胞渗透性OGT（O-GlcNAc转移酶）抑制剂。
在翻译后修饰过程中，OGT可催化 N-乙酰葡糖胺部分与多种蛋白质的连接。抑制OGT活性，可能会降低病毒在感染过程中的复制率，如单纯疱疹病毒性疾病。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulation of the hippo-YAP pathway by glucose sensor O-GlcNAcylation.
Peng C, et al.
Molecular Cell, 68(3), 591-604 (2018)
O-GlcNAc transferase inhibitors: current tools and future challenges.
Trapannone R, et al.
Biochemical Society Transactions, 44(1), 88-93 (2016)
O-GlcNAc modification of oncogenic transcription factor Sox2 promotes protein stability and regulates self-renewal in pancreatic cancer.
Sharma N, et al.
bioRxiv, 345223-345223 (2018)
Nikita S Sharma et al.
Theranostics, 9(12), 3410-3424 (2019-07-10)
Pancreatic adenocarcinoma (PDAC) claims more than 90% of the patients diagnosed with the disease owing to its aggressive biology that is manifested by high rate of tumor recurrence. Aberrant upregulation in the transcriptional activity of proteins involved in self-renewal like
Hye-Yeon Kim et al.
Bioprocess and biosystems engineering, 43(5), 863-875 (2020-01-26)
O-Glycosylation occurs in recombinant proteins produced by CHO cells, but this phenomenon has not been studied extensively. Here, we report that rituximab is an O-linked N-acetyl-glucosaminylated (O-GlcNAcylated) protein and the production of rituximab is increased by thiamet G, an inhibitor
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持